{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:25:05Z","timestamp":1773836705016,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,5,28]],"date-time":"2008-05-28T00:00:00Z","timestamp":1211932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1245\/s10434-008-9940-z","type":"journal-article","created":{"date-parts":[[2008,5,27]],"date-time":"2008-05-27T20:43:00Z","timestamp":1211920980000},"page":"2318-2328","source":"Crossref","is-referenced-by-count":103,"title":["High Histone Deacetylase 7 (HDAC7) Expression Is Significantly Associated with Adenocarcinomas of the Pancreas"],"prefix":"10.1245","volume":"15","author":[{"given":"Mehdi","family":"Oua\u00efssi","sequence":"first","affiliation":[]},{"given":"Igor","family":"Sielezneff","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Silvestre","sequence":"additional","affiliation":[]},{"given":"Bernard","family":"Sastre","sequence":"additional","affiliation":[]},{"given":"Jean-Paul","family":"Bernard","sequence":"additional","affiliation":[]},{"given":"Joelle Simony","family":"Lafontaine","sequence":"additional","affiliation":[]},{"given":"Marie Jos\u00e9","family":"Payan","sequence":"additional","affiliation":[]},{"given":"Laetitia","family":"Dahan","sequence":"additional","affiliation":[]},{"given":"Nicolas","family":"Pirr\u00f2","sequence":"additional","affiliation":[]},{"given":"Jean Fran\u00e7ois","family":"Seitz","sequence":"additional","affiliation":[]},{"given":"Eric","family":"Mas","sequence":"additional","affiliation":[]},{"given":"Dominique","family":"Lombardo","sequence":"additional","affiliation":[]},{"given":"Ali","family":"Ouaissi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,5,28]]},"reference":[{"key":"9940_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","volume":"50","author":"RT Greenlee","year":"2000","unstructured":"Greenlee RT, Murray T, Bolden S, et al. Cancer statistics. Cancer J Clin 2000; 50:7\u201333.","journal-title":"Cancer J Clin"},{"key":"9940_CR2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/1096-9098(200008)74:4<243::AID-JSO1>3.0.CO;2-C","volume":"74","author":"M Goggins","year":"2000","unstructured":"Goggins M, Canto M, Hruban R. Can we screen high-risk individuals to detect early pancreatic carcinoma? J Surg Oncol 2000; 74:243\u20138.","journal-title":"J Surg Oncol"},{"key":"9940_CR3","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2165\/00003495-200059050-00004","volume":"59","author":"L Rosenberg","year":"2000","unstructured":"Rosenberg L. Pancreatic cancer: a review of emerging therapies. Drugs 2000; 59:1071\u201389.","journal-title":"Drugs"},{"key":"9940_CR4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000658-200201000-00007","volume":"235","author":"B Gerdes","year":"2002","unstructured":"Gerdes B, Ramaswamy A, Ziegler A, et al. p16INK4a is a prognostic marker in resected ductal pancreatic cancer. Ann Surg 2002; 235:51\u20139.","journal-title":"Ann Surg"},{"key":"9940_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7","volume":"184","author":"WD Cress","year":"2000","unstructured":"Cress WD, Seto E. Histone deacetylase, transcriptional control and cancer. J Cell Physiol 2000; 184:1\u201316.","journal-title":"J Cell Physiol"},{"key":"9940_CR6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00001622-200111000-00010","volume":"13","author":"PA Marks","year":"2001","unstructured":"Marks PA. Histone deacetylase inhibitors as a new drugs. Curr Opin Oncol 2001; 13:477\u201383.","journal-title":"Curr Opin Oncol"},{"key":"9940_CR7","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/PL00000896","volume":"58","author":"S Timmermann","year":"2001","unstructured":"Timmermann S. Histone acetylation and disease. Cell Mol Life Sci 2001; 58:728\u201336.","journal-title":"Cell Mol Life Sci"},{"key":"9940_CR8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3727\/000000001783992687","volume":"9","author":"AT Amunziato","year":"2000","unstructured":"Amunziato AT, Hansen JC. Role of histone acetylation in the assembly and modulation of chromatin structures. Gene Expr 2000; 9:37\u201361.","journal-title":"Gene Expr"},{"key":"9940_CR9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","volume":"5","author":"JE Bolden","year":"2006","unstructured":"Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006; 5:769\u201384.","journal-title":"Nat Rev Drug Discov"},{"key":"9940_CR10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1006\/bbrc.2000.3000","volume":"273","author":"RA Frye","year":"2000","unstructured":"Frye RA. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 2000; 273:793\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"9940_CR11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bjc.6600156","volume":"86","author":"F Nigris De","year":"2002","unstructured":"De Nigris F, Cerutti J, Morelli C, et al. Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues. Br J Cancer 2002; 86:917\u201323.","journal-title":"Br J Cancer"},{"key":"9940_CR12","doi-asserted-by":"crossref","unstructured":"Greene FL, Page DL, Fleming ID, et al., eds. AJCC Cancer Staging Handbook, 6th edition. American Joint Committee on Cancer. New York: Springer Verlag, 2002","DOI":"10.1007\/978-1-4757-3656-4"},{"key":"9940_CR13","doi-asserted-by":"crossref","first-page":"10881","DOI":"10.1093\/nar\/16.22.10881","volume":"22","author":"F Corpet","year":"1988","unstructured":"Corpet F. Multiple sequence alignment with hierarchical clustering. Nucl Acids Res 1988; 22:10881\u201390.","journal-title":"Nucl Acids Res"},{"key":"9940_CR14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394Ct method. Methods 2001; 25:402\u20138.","journal-title":"Methods"},{"key":"9940_CR15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1172\/JCI29562","volume":"117","author":"AM Avila","year":"2007","unstructured":"Avila AM, Burnett BG, Taye AA, et al. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J Clin Inv 2007; 117:659\u201371.","journal-title":"J Clin Inv"},{"key":"9940_CR16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1083\/jcb.200412101","volume":"169","author":"S Shen","year":"2005","unstructured":"Shen S, Li J, Casaccia-Bonnefil P. Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing brain. J Cell Biol 2005; 169:577\u201388.","journal-title":"J Cell Biol"},{"key":"9940_CR17","first-page":"1819","volume":"13","author":"TM Gress","year":"1996","unstructured":"Gress TM, Muller-Pillasch F, Geng M, et al. A pancreatic cancer-specific expression profile. Oncogene 1996; 13:1819\u201330.","journal-title":"Oncogene"},{"key":"9940_CR18","doi-asserted-by":"crossref","first-page":"7437","DOI":"10.1038\/sj.onc.1204935","volume":"20","author":"T Crnogorac-Jurcevic","year":"2001","unstructured":"Crnogorac-Jurcevic T, Efthimiou E, Capelli P, et al. Gene expression profiles of pancreatic cancer and stromal desmoplasia. Oncogene 2001; 20:7437\u201346.","journal-title":"Oncogene"},{"key":"9940_CR19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrc755","volume":"2","author":"D Sidransky","year":"2002","unstructured":"Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2002; 2:210\u20139.","journal-title":"Nat Rev Cancer"},{"key":"9940_CR20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0889-8588(01)00007-7","volume":"16","author":"C Rosty","year":"2002","unstructured":"Rosty C, Goggind M. Early detection of pancreatic carcinoma. Hematol Oncol Clin North Am 2002; 16:37\u201352.","journal-title":"Hematol Oncol Clin North Am"},{"key":"9940_CR21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ng892","volume":"31","author":"H Suzuki","year":"2002","unstructured":"Suzuki H, Gabrielson E, Chen W, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002; 31:141\u20139.","journal-title":"Nat Genet"},{"key":"9940_CR22","first-page":"8614","volume":"63","author":"CA Iacobuzio-Donahue","year":"2003","unstructured":"Iacobuzio-Donahue CA, Ashfaq A, Maitra A, et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 2003; 63:8614\u201322.","journal-title":"Cancer Res"},{"key":"9940_CR23","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrc949","volume":"2","author":"N Bardeey","year":"2002","unstructured":"Bardeey N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer 2002; 2:897\u2013909.","journal-title":"Nat Rev Cancer"},{"key":"9940_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/path.1418","volume":"201","author":"T Crnogorac-Jurcevic","year":"2003","unstructured":"Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, et al. Molecular alterations in pancreatic carcinoma expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol 2003; 201:63\u201374.","journal-title":"J Pathol"},{"key":"9940_CR25","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1002\/pmic.200300466","volume":"3","author":"A Shekouh","year":"2003","unstructured":"Shekouh A, Thompson CC, Prime W, et al. Development and application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics 2003; 3:1988\u20132001.","journal-title":"Proteomics"},{"key":"9940_CR26","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1158\/0008-5472.CAN-04-4311","volume":"65","author":"D Vimalachandran","year":"2005","unstructured":"Vimalachandran D, Greenhalf W, Thompson C, et al. High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients. Cancer Res 2005; 65:3218\u201325.","journal-title":"Cancer Res"},{"key":"9940_CR27","first-page":"251","volume":"7","author":"RH Hruban","year":"2001","unstructured":"Hruban RH, Iacobuzio-Donahue C, Wilentz RE, et al. Molecular pathology of pancreatic cancer. Cancer J 2001; 7:251\u20138.","journal-title":"Cancer J"},{"key":"9940_CR28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ijc.2910620507","volume":"62","author":"M Ebert","year":"1995","unstructured":"Ebert M, Yokoyama M, Friess H, et al. Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer. Int J Cancer 1995; 62:529\u201335.","journal-title":"Int J Cancer"},{"key":"9940_CR29","first-page":"2704","volume":"53","author":"H Friess","year":"1993","unstructured":"Friess H, Yamanaka Y, B\u00fcchler M. Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res 1993; 53:2704\u20137.","journal-title":"Cancer Res"},{"key":"9940_CR30","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1349-7006.2001.tb02153.x","volume":"92","author":"JH Choi","year":"2001","unstructured":"Choi JH, Kwon HJ, Yoon BI, et al. Expression profile of histone deacetylase 1 in gastric cancer tissues. Jpn J Cancer Res 2001; 92:1300\u20134.","journal-title":"Jpn J Cancer Res"},{"key":"9940_CR31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1535-6108(04)00114-X","volume":"5","author":"P Zhu","year":"2004","unstructured":"Zhu P, Martin E, Mengwasser J, Schlag P, et al. Induction of HDAC2 expression upon loss of APC in colorectal tumorogenesis. Cancer Cell 2004; 5:455\u201363.","journal-title":"Cancer Cell"},{"key":"9940_CR32","doi-asserted-by":"crossref","first-page":"13548","DOI":"10.1074\/jbc.M510023200","volume":"281","author":"AJ Wilson","year":"2006","unstructured":"Wilson AJ, Byun DS, Popova N, et al. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem 2006; 281:13548\u201358.","journal-title":"J Biol Chem"},{"key":"9940_CR33","first-page":"4041","volume":"62","author":"MJ Scanlan","year":"2002","unstructured":"Scanlan MJ, Welt S, Gordon CM, et al. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Cancer Res 2002; 62:4041\u20137.","journal-title":"Cancer Res"},{"key":"9940_CR34","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.bbrc.2003.08.029","volume":"309","author":"M Hiratsuka","year":"2003","unstructured":"Hiratsuka M, Inoue T, Toda T, et al. Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene. Biochem Biophys Res Commun 2003; 309:558\u201366.","journal-title":"Biochem Biophys Res Commun"},{"key":"9940_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/JBB\/2006\/13474","volume":"13474","author":"M Ouaissi","year":"2006","unstructured":"Ouaissi M, Ouaissi A. Histone deacetylase enzymes as potential drug targets in cancer and parasitic diseases. J Biomed Biotechnol 2006; 13474:1\u201310.","journal-title":"J Biomed Biotechnol"},{"key":"9940_CR36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nbt1272","volume":"25","author":"PA Marks","year":"2007","unstructured":"Marks PA, Breslow R. Dimethyl sulfoxide to vorinostat: development of the histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol 2007; 25:84\u201390.","journal-title":"Nat Biotechnol"},{"key":"9940_CR37","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1158\/1535-7163.MCT-07-0251","volume":"6","author":"M Dokmanovic","year":"2007","unstructured":"Dokmanovic M, Perez G, Xu W, et al. Histone deacetylase inhibitors selectively suppress expression of HDAC7. Mol Cancer Ther 2007; 6:2525\u201334.","journal-title":"Mol Cancer Ther"},{"key":"9940_CR38","first-page":"1794","volume":"18","author":"D Mottet","year":"2007","unstructured":"Mottet D, Bellahc\u00e8ne A, Pirotte S. HDAC7 silencing alters endothelial cell migration, a key step in angiogenesis. Cir Res 2007; 18:1794\u2013801.","journal-title":"Cir Res"},{"key":"9940_CR39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1074-7613(03)00109-2","volume":"18","author":"F Dequiedt","year":"2003","unstructured":"Dequiedt F, Kasler H, Fischle W, et al. HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. Immunity 2003:18:687\u201398.","journal-title":"Immunity"},{"key":"9940_CR40","doi-asserted-by":"crossref","first-page":"47496","DOI":"10.1074\/jbc.M107631200","volume":"276","author":"HY Kao","year":"2001","unstructured":"Kao HY, Verdel A, Tsai CC, et al. Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7. J Biol Chem 2001; 276:47496\u2013507.","journal-title":"J Biol Chem"},{"key":"9940_CR41","doi-asserted-by":"crossref","first-page":"13762","DOI":"10.1074\/jbc.M413396200","volume":"280","author":"M Parra","year":"2005","unstructured":"Parra M, Kasler H, McKinsey TA, et al. Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation. J Biol Chem 2005; 280:13762\u201370.","journal-title":"J Biol Chem"},{"key":"9940_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1072-7515(99)00075-7","volume":"189","author":"S Sener","year":"1999","unstructured":"Sener S, Frengen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100313 patients diagnosed from 1985\u20131995, using the National Cancer Database. J Am Coll Surg 1999; 189:1\u20137.","journal-title":"J Am Coll Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-008-9940-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-008-9940-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-008-9940-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T11:31:45Z","timestamp":1572953505000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-008-9940-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5,28]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["9940"],"URL":"https:\/\/doi.org\/10.1245\/s10434-008-9940-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,28]]}}}